Find in Library

A first-in-man, double blind, placebo controlled study of the candidate therapeutic vaccine Opal-HIV-Gag(c) in HIV infected patients receiving HAART

oleh: Jackson AG, Kløverpris HN, Handley A, Hayes P, Gilmour J, Atkins M, Walker B, Ackland J, Sullivan M, Goulder P